Get started
Author

Shaily Pandey

Observed names: Pandey, Shaily, S Pandey
OpenAlex ID: A5084522279
Melanoma Epidemiology and Prevention
2015 · Marianne Berwick, David B. Buller, et al. · Cancer treatment and research · 149
Examining the Efficacy and Safety of Squaric Acid Therapy for Treatment of Recalcitrant Warts in Children
2014 · Shaily Pandey, Erin N. Wilmer, et al. · Pediatric Dermatology · 17
IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2015 · Craig C. Carson, Stergios J. Moschos, et al. · Clinical Cancer Research · 16
Evaluation of the prognostic significance of follicular extension in actinic keratoses.
2012 · Shaily Pandey, Stephen E Mercer, et al. · PubMed · 11
Sporotrichosis in the nail—An unusual location and presentation
2017 · Krista N. Larson, Shaily Pandey, et al. · JAAD Case Reports · 7
PDF
Leukemia cutis presenting clinically as disseminated herpes zoster in a patient with unrecognized acute promyelocytic leukemia.
2012 · Marianna Shvartsbeyn, Shaily Pandey, et al. · PubMed · 2
Closing The Digital Divide: Gendering The G20 To Promote Women's Tech Literacy
2023 · Pandey, Shaily, Singh Shakya, Abhinav · Zenodo (CERN European Organization for Nuclear Research)
Supplementary Tables 3 and 4 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
PDF
Supplementary Table 1 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
PDF
Supplementary Figure 2 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
Supplementary Figure 1 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
Supplementary Table 2 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
Supplementary Table 6 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
PDF
Supplementary Table 5 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
Supplementary Figure legends from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
Data from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
Data from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
Supplementary Figure legends from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
Supplementary Table 1 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
Supplementary Table 6 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
Supplementary Table 5 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
PDF
Supplementary Figure 1 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
PDF
Supplementary Table 2 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
PDF
Supplementary Figure 2 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
PDF
Supplementary Tables 3 and 4 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
Works count: 28
Citation count: 202
H-index: 5
I10-index: 4
Year
Topic
Type